Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer - Concepedia

Concepedia

Publication | Open Access

Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer

DOI Full Paper Access

133

Citations

39

References

2022

Year

Aleix Prat, Valentina Guarneri, Tomás Pascual, Fara Brasó‐Maristany, Esther Sanfeliu, Laia Paré, Francesco Schettini, Pedro Jares, Gaia Griguolo, Maria Vittoria Dieci,

References

	Year	Citations

Page 1